4.7 Article

Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 14, Issue 4, Pages 722-728

Publisher

ELSEVIER
DOI: 10.1016/j.intimp.2012.10.010

Keywords

Organotypic co-culture; Caco-2 cells; Whole blood culture; Ibuprofen; Prednisolone; Cytokines

Funding

  1. German Federal Ministry of Education and Research (BMBF) [FKZ 01GG0716, 01GG717]

Ask authors/readers for more resources

The human immune system represents a highly complex multicellular network that protects the organism against the environment and pathogens. Within this system, different immune cells communicate with each other, as well as with adjacent organs and tissues, using an impressive network of regulatory signals. This inherent complexity makes it rather difficult to mimic these processes in vitro. Unpredictable drug-induced side effects can be the consequence when moving from preclinical animal models into clinical phase. Therefore, there is a demand for more elaborate in vivo like human cell culture models. In this study, an in vitro co-culture model consisting of Caco-2 human gut epithelial cells and human whole blood representing the immune system is applied to investigate the intestinal absorption of anti-inflammatory drugs and the subsequent modulation of the immunoregulatory signaling processes. By using blood of different donors, the individuality of the immune system is integrated into the overall analysis. The anti-inflammatory drugs prednisolone and ibuprofen were applied on top of the Caco-2 epithelial cells and alterations in the extracellular communication via cytokines and chemokines were visualized using miniaturized multiplexed sandwich immunoassays. Optionally, pretreatment of the Caco-2 epithelial cells with pro-inflammatory mediators can be used to modulate the epithelial barrier function similar to the situation observed during inflammatory conditions of the gut. The presented translational test system, consisting of differentiated Caco-2 intestinal epithelial cells and whole blood substantially improves preclinical screening of immunologically active drugs with respect to an approximation of the human in vivo conditions. (c) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern

Teresa R. Wagner, Daniel Schnepf, Julius Beer, Natalia Ruetalo, Karin Klingel, Philipp D. Kaiser, Daniel Junker, Martina Sauter, Bjoern Traenkle, Desiree Frecot, Matthias Becker, Nicole Schneiderhan-Marra, Annette Ohnemus, Martin Schwemmle, Michael Schindler, Ulrich Rothbauer

Summary: The study identified two high-affinity biparatopic nanobodies that can neutralize multiple emerging SARS-CoV-2 variants, providing protection against virus infection in vivo and demonstrating a significant reduction in disease progression.

EMBO REPORTS (2022)

Article Multidisciplinary Sciences

Robust and durable serological response following pediatric SARS-CoV-2 infection

Hanna Renk, Alex Dulovic, Alina Seidel, Matthias Becker, Dorit Fabricius, Maria Zernickel, Daniel Junker, Ruediger Gross, Janis Mueller, Alexander Hilger, Sebastian F. N. Bode, Linus Fritsch, Pauline Frieh, Anneke Haddad, Tessa Goerne, Jonathan Remppis, Tina Ganzemueller, Andrea Dietz, Daniela Huzly, Hartmut Hengel, Klaus Kaier, Susanne Weber, Eva-Maria Jacobsen, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Maximilian Stich, Burkhard Toenshoff, Georg F. Hoffmann, Barbara Mueller, Carolin Ludwig, Bernd Jahrsdoerfer, Hubert Schrezenmeier, Andreas Peter, Sebastian Hoerber, Thomas Iftner, Jan Muench, Thomas Stamminger, Hans-Juergen Gross, Martin Wolkewitz, Corinna Engel, Weimin Liu, Marta Rizzi, Beatrice H. Hahn, Philipp Henneke, Axel R. Franz, Klaus-Michael Debatin, Nicole Schneiderhan-Marra, Ales Janda, Roland Elling

Summary: This study compares the humoral immune response in children and adults following SARS-CoV-2 infection and finds that children are more likely to have asymptomatic infections and higher levels of specific antibodies that persist for a longer time. Symptomatic and asymptomatic infections induce similar humoral responses across all age groups.

NATURE COMMUNICATIONS (2022)

Article Immunology

Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany

Alex Dulovic, Barbora Kessel, Manuela Harries, Matthias Becker, Julia Ortmann, Johanna Griesbaum, Jennifer Juengling, Daniel Junker, Pilar Hernandez, Daniela Gornyk, Stephan Gloeckner, Vanessa Melhorn, Stefanie Castell, Jana-Kristin Heise, Yvonne Kemmling, Torsten Tonn, Kerstin Frank, Thomas Illig, Norman Klopp, Neha Warikoo, Angelika Rath, Christina Suckel, Anne Ulrike Marzian, Nicole Grupe, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Tobias Kerrinnes, Gerard Krause, Berit Lange, Nicole Schneiderhan-Marra, Monika Strengert

Summary: Recent increases in SARS-CoV-2 infections have raised questions about the duration and quality of vaccine-induced immune protection. This study analyzed samples from a large population-based seroprevalence study in Germany and found that mRNA-based or heterologous prime-boost vaccination resulted in higher antibody responses compared to vector-based homologous vaccination. Previously infected individuals had a robust immune response after vaccination, regardless of the vaccine received.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants

Daniel Junker, Alex Dulovic, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Bjoern Traenkle, Katharina Kienzle, Stefanie Bunk, Carlotta Struemper, Helene Haeberle, Kristina Schmauder, Natalia Ruetalo, Nisar Malek, Karina Althaus, Michael Koeppen, Ulrich Rothbauer, Juliane S. Walz, Michael Schindler, Michael Bitzer, Siri Gopel, Nicole Schneiderhan-Marra

Summary: This study developed a new serological multiplex assay to analyze ACE2 binding inhibition of SARS-CoV-2 VOCs and VOIs. The study found that ACE2 binding inhibition correlated with disease severity and antibody levels in COVID-19 patients.

SCIENTIFIC REPORTS (2022)

Article Clinical Neurology

CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers

Stefanie Lerche, Milan Zimmermann, Isabel Wurster, Benjamin Roeben, Franca Laura Fries, Christian Deuschle, Katharina Waniek, Ingolf Lachmann, Thomas Gasser, Meike Jakobi, Thomas O. Joos, Nicole Schneiderhan-Marra, Kathrin Brockmann

Summary: The study found limited correlations between central-nervous and peripheral inflammatory markers in Parkinson's disease patients, with important pro-inflammatory mediators associated with motor and cognitive decline as well as neurodegenerative/PD-specific biomarkers, and these results were more robust in cerebrospinal fluid. Sex-specific characteristics have significant implications for the design of clinical trials targeting the immune system for disease modification.

FRONTIERS IN NEUROLOGY (2022)

Article Critical Care Medicine

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19

Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, Oltin T. Pop, Ann-Kristin Jochum, Lorenz Risch, Silvio D. Brugger, Ana Velic, David Bomze, Philipp Kohler, Pietro Vernazza, Werner C. Albrich, Christian R. Kahlert, Marie-Therese Abdou, Nina Wyss, Kathrin Hofmeister, Heike Niessner, Carl Zinner, Mara Gilardi, Alexandar Tzankov, Martin Rocken, Alex Dulovic, Srikanth Mairpady Shambat, Natalia Ruetalo, Philipp K. Buehler, Thomas C. Scheier, Wolfram Jochum, Lukas Kern, Samuel Henz, Tino Schneider, Gabriela M. Kuster, Maurin Lampart, Martin Siegemund, Roland Bingisser, Michael Schindler, Nicole Schneiderhan-Marra, Hubert Kalbacher, Kathy D. McCoy, Werner Spengler, Martin H. Brutsche, Boris Macek, Raphael Twerenbold, Josef M. Penninger, Matthias S. Matter, Lukas Flatz

Summary: COVID-19 can cause severe respiratory distress syndrome, and dysregulated immune responses, including autoimmunity, play a key role. This study investigated the presence of IgA autoantibodies targeting lung-specific proteins and their effects on pulmonary surfactant in severe COVID-19 cases.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Immunology

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants

Daniel Junker, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Sandra Maier, Tanja M. Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T. Pinilla, Jana Held, Rolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S. Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Goepel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R. Franz, Manuela Harries, Barbora Kessel, Berit Lange, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, Alex Dulovic, Nicole Schneiderhan-Marra

Summary: Using a large diverse cohort, this study found that the Omicron variant can bind to ACE2 more efficiently than inhibitory antibodies. Antibodies elicited by infection or immunization showed reduced binding capacities and ACE2 binding inhibition compared to wild type. Both Omicron variants are able to evade control by preexisting antibodies.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients

Matthias Becker, Anne Cossmann, Karsten Luerken, Daniel Junker, Jens Gruber, Jennifer Juengling, Gema Morillas Ramos, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Metodi Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gerard Krause, Nicole Schneiderhan-Marra, Monika Strengert, Alex Dulovic, Georg M. N. Behrens

Summary: Haemodialysis patients have poor response to vaccination, but their immune protection can be improved by receiving a fourth COVID-19 vaccine dose. This study provides longitudinal vaccination response data in dialysis patients and controls after triple BNT162b2 vaccination and subsequent fourth full-dose mRNA-1273 vaccination. The results show that the fourth dose significantly enhances the immune response against various SARS-CoV-2 variants in dialysis patients. Therefore, a four-dose COVID-19 immunisation scheme is recommended for haemodialysis patients to prevent severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study

Anneke Haddad, Ales Janda, Hanna Renk, Maximilian Stich, Pauline Frieh, Klaus Kaier, Florens Lohrmann, Alexandra Nieters, Anna Willems, Daniela Huzly, Alex Dulovic, Nicole Schneiderhan-Marra, Eva-Maria Jacobsen, Dorit Fabricius, Maria Zernickel, Thomas Stamminger, Sebastian F. N. Bode, Theda Himpel, Jonathan Remppis, Corinna Engel, Andreas Peter, Tina Ganzenmueller, Georg Friedrich Hoffmann, Bettina Haase, Hans-Georg Krausslich, Barbara Muller, Axel R. Franz, Klaus-Michael Debatin, Burkhard Tonshoff, Philipp Henneke, Roland Elling

Summary: Long COVID symptoms were examined in a cohort of infected children, adolescents, and adults and their exposed but non-infected household members approximately 1 year after infection. The study found a higher prevalence of moderate or severe persistent symptoms in infected women, men, and adolescent girls compared to their exposed counterparts. Clustering of persistent symptoms within households was also observed.

EBIOMEDICINE (2022)

Article Infectious Diseases

Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies

Julia Haring, Max J. Hassenstein, Matthias Becker, Julia Ortmann, Daniel Junker, Andre Karch, Klaus Berger, Tatia Tchitchagua, Olaf Leschnik, Manuela Harries, Daniela Gornyk, Pilar Hernandez, Berit Lange, Stefanie Castell, Gerard Krause, Alex Dulovic, Monika Strengert, Nicole Schneiderhan-Marra

Summary: A multiplex Borrelia immunoassay was developed in this study, which showed high sensitivity and specificity in detecting antibodies against multiple Borrelia species. This assay provides a cost-effective and time-saving method for the diagnosis and identification of Lyme borreliosis.

BMC INFECTIOUS DISEASES (2022)

Article Virology

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates

Guenalp Uzun, Rebecca Mueller, Karina Althaus, Matthias Becker, Patrick Marsall, Daniel Junker, Stefanie Nowak-Harnau, Nicole Schneiderhan-Marra, Harald Klueter, Hubert Schrezenmeier, Peter Bugert, Tamam Bakchoul

Summary: This study investigated the relationship between clinical donor characteristics and neutralizing anti-SARS-CoV-2 antibodies in COVID-19 convalescent plasma (CCP) donors. Time since symptom onset, BMI, and fever were found to be associated with neutralizing capacity. These clinical parameters can be easily incorporated into the preselection of CCP donors.

VIRUSES-BASEL (2023)

Article Neurosciences

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD

Stefanie Lerche, Milan Zimmermann, Benjamin Roeben, Isabel Wurster, Franca Laura Fries, Christian Deuschle, Katharina Waniek, Ingolf Lachmann, Meike Jakobi, Thomas O. Joos, Thomas Knorpp, Nicole Schneiderhan-Marra, Kathrin Brockmann

Summary: Inflammation is linked to the incidence and progression of Parkinson's disease (PD). A study found that certain inflammatory markers in the cerebrospinal fluid (CSF) were associated with clinical scores and neurodegenerative CSF biomarkers in PD and dementia with Lewy bodies (DLB) patients. The presence of GBA mutations did not significantly affect the levels of inflammatory markers in PD patients. The study also showed that higher levels of TNF-alpha, VEGF, and MIP-1 beta were associated with the development of cognitive impairment in PD patients.

NPJ PARKINSONS DISEASE (2023)

Article Gastroenterology & Hepatology

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Simon Woelfel, Joel Duetschler, Marius Koenig, Alex Dulovic, Nicole Graf, Daniel Junker, Vasileios Oikonomou, Claudia Krieger, Samuel Truniger, Annett Franke, Annika Eckhold, Kristina Forsch, Seraina Koller, Jacqueline Wyss, Niklas Krupka, Melanie Oberholzer, Nicola Frei, Nora Geissler, Peter C. Schaub, Matthias STAR SIGN Study Investigator, Werner Albrich, Matthias Friedrich, Nicole Schneiderhan-Marra, Benjamin J. Misselwitz, Wolfgang Korte, Justus Buergi, Stephan Brand

Summary: This study aimed to assess the immunization efficacy against the novel omicron sublineages BQ.1.1 and XBB.1.5 in immunosuppressed patients with IBD. The results showed that anti-TNF biologic-treated patients with IBD had impaired neutralization and inadequate surrogate neutralization against the tested sublineages compared to non-anti-TNF biologic-treated patients and healthy controls. Therefore, these patients may benefit from prioritization for future variant-adapted vaccines.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Multidisciplinary Sciences

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Julia Haering, Tanja Michel, Matthias Becker, Daniel Junker, Tatia Tchitchagua, Olaf Leschnik, Berit Lange, Stefanie Castell, Gerard Krause, Monika Strengert, Alex Dulovic, Nicole Schneiderhan-Marra

Summary: To monitor infectious diseases, it is important to assess immunoreactivity and measure different antibody isotypes at different stages of the immune response. Lyme borreliosis can be caused by various Borrelia species, so correct classification of samples requires evaluating immunoreactivity against different antigens. This study demonstrates a dual-reporter multiplex immunoassay that allows simultaneous evaluation of IgG and IgM immunoreactivity against different bacterial antigens, providing more serological information in less time.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2023)

Article Multidisciplinary Sciences

Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system

Serafina Calarco, B. Leticia Fernandez-Carballo, Thomas Keller, Stephan Weber, Meike Jakobi, Patrick Marsall, Nicole Schneiderhan-Marra, Sabine Dittrich

Summary: This study compared the analytical performance of 17 commercially available POC CRP tests and found that two quantitative tests performed better than the others, while the performance of semi-quantitative tests was unstable. Quantitative tests may be the best choice for different CRP ranges.

PLOS ONE (2023)

Article Immunology

IFITM3 overexpression reverses insufficient healing benefits of small extracellular vesicles from high-fat-diet BMSCs in sepsis via the HMGB1 pathway

Jun Cui, Cheng Chen, Xiao Zhou, Wenju Shan, Yuhong Jian, Panpan Li, Yang Sun, Wei Yi

Summary: Bone marrow mesenchymal stem cells (BMSCs) are a promising therapy for sepsis, but metabolic syndromes threaten their effectiveness. This study investigated the potential of small extracellular vesicles from high-fat diet BMSCs in sepsis-induced liver-heart axis injury.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

MMP-9 inhibition alleviates postoperative cognitive dysfunction by improving glymphatic function via regulating AQP4 polarity

Binbin Zhu, Angyang Cao, Chunqu Chen, Weijian Zhou, Wenjun Luo, Yu Gui, Qinwen Wang, Zhipeng Xu, Jianhua Wang

Summary: GM6001 alleviates postoperative cognitive deficits and neuroinflammation, preserves blood-brain barrier integrity, and rescues aquaporin-4 mislocalization. MMP-9 inhibition plays a dual role in cognitive protection through direct anti-neuroinflammatory effects and regulation of aquaporin-4 membrane distribution.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

S1PR2 inhibition mitigates cognitive deficit in diabetic mice by modulating microglial activation via Akt-p53-TIGAR pathway

Anika Sood, Valencia Fernandes, Kumari Preeti, Shruti Rajan, Dharmendra Kumar Khatri, Shashi Bala Singh

Summary: S1PR2 inhibitor improves cognitive function and skews microglia toward anti-inflammatory phenotype in type 2 diabetic mice, promising to be a potential therapy for neuroinflammation.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Cytokine, chemokine alterations and immune cell infiltration in Radiation-induced lung injury: Implications for prevention and management

Haochun Guo, Ran Yu, Haijun Zhang, Wanpeng Wang

Summary: Radiation therapy is an effective treatment for thoracic malignancies, but it can cause radiation-induced lung injury (RILI), including radiation pneumonitis (RP) and radiation pulmonary fibrosis (RPF). The damage to normal lung cells during radiation treatment leads to a pulmonary inflammatory response, resulting in RP and RPF.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers

Guanghui Wang, Haotian Zheng, Yunzhi Xiang, Yadong Wang, Kai Wang, Xiaoyang Ren, Jiajun Du

Summary: This study identified a T-cell synthetic driver-associated prognostic model that accurately predicted prognosis and effectiveness of immunotherapy in LUAD patients. It also highlighted the role of LDHA in promoting tumor cell proliferation, invasion, and resistance to treatment, as well as its involvement in immune escape within the tumor microenvironment. These findings provide a promising new therapeutic strategy for LUAD.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Identification of immunological characteristics and cuproptosis-related molecular clusters in primary Sjogren's syndrome

Bowen Wei, Aihua Wang, Wei Liu, Qingyun Yue, Yihua Fan, Bin Xue, Siwei Wang

Summary: This study systematically analyzed the association between pSS and cuproptosis, established a predictive model based on 5 genes, explored the pathogenic mechanisms and novel therapeutic strategies for pSS, and identified EED, CBL, and NFU1 as potential targets for treatment.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Site-selective synthesis and pharmacological elucidation of novel semi-synthetic analogues of koenimbine as a potential anti-inflammatory agent

Nusrit Iqbal Andrabi, Aminur R. Sarkar, Syed Assim Haq, Diljeet Kumar, Dilpreet Kour, Diksha Saroch, Sanket Kumar Shukla, Ajay Kumar, Asha Bhagat, Asif Ali, Gurleen Kour, Zabeer Ahmed

Summary: Koenimbine and its novel semi-synthetic derivative 1G demonstrate significant anti-inflammatory effects by downregulating the nuclear factor kappa-B (NF-kappa B) signaling pathway.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Protective effect of arctiin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor

Jing-Mei Lu, Xiang Xu, Fumie Aosai, Ming-Yue Zhang, Lian-Xun Piao

Summary: This study found that arctiin can improve allergic acute liver injury caused by T.g.HSP70 by inhibiting TLR4 signaling and reducing the production of inflammatory mediators.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Arabinose confers protection against intestinal injury by improving integrity of intestinal mucosal barrier

Minxuan Xu, Fang Shi, Yongshen Gao, Shumei Han, Chensuo Huang, Qinsheng Hou, Xiaoweng Wen, Bengshi Wang, Zhenyu Zhu, Lei Zou, Mingxin Xiong, Wei Dong, Jun Tan

Summary: There is a growing body of research highlighting the involvement of metabolic imbalance and the inflammatory response in the advancement of colitis. This study recognizes arabinose as a significant protector of the intestinal mucosal barrier, reducing damage to the intestines. In addition, lower levels of arabinose in the bloodstream are associated with a higher severity of inflammatory bowel disease and colorectal cancer.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2

Yueqing Han, Haoxin Song, Yanshan Li, Rongxin Li, Ling Chen, Bo Gao, Yijun Chen, Shuzhen Wang

Summary: The combination of tetracycline antibiotics, demeclocycline (D), chlortetracycline (C), and minocycline (M), showed therapeutic potential against liver fibrosis by inhibiting the activation of hepatic stellate cells and the MAPK signaling. This study suggests that tetracyclines may be repurposed for the treatment of liver fibrosis.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Spleen contributes to chronic restraint stress-induced lung injury through splenic CD11b+cells

Yu Li, Hailing Liu, Danwen Zhao, Danjie Zhang

Summary: Chronic stress can lead to lung injury, with the spleen playing a crucial role. This study found that the spleen contributes to chronic restraint stress-induced lung injury, and splenic CD11b+ cells may be an important factor in this process.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

NMAAP1 regulated macrophage polarizion into M1 type through glycolysis stimulated with BCG

Yingqian Mi, Mengyan Tang, Qiong Wu, Yinan Wang, Qihui Liu, Pei Zhu, Xiaoyang Xue, Yuntong Liu, Xinyu Chai, Yuyang Hou, Dongmei Yan

Summary: BCG therapy can induce macrophage polarization to the M1 type, and NMAAP1 plays a crucial role in this process by regulating glycolysis and HIF-1α expression. This promotes the antitumor effect of macrophages.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques

Xiaosheng Liu, Tingxia Lv, Xiuxia Li, Jing Xue, Ling Lin, Lianfeng Lu, Xiaodi Li, Yang Yang, Yuanni Wu, Qiang Wei, Wei Cao, Taisheng Li

Summary: LLDT-8 exhibits notable efficacy in alleviating immune activation in both an in vivo animal model and in vitro human cell experiments, suggesting its potential as a drug for managing systemic immune activation associated with SIV/HIV infection.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Mesenchymal stem cells attenuate systemic lupus erythematosus by inhibiting NLRP3 inflammasome activation through Pim-1 kinase

Honghong Yu, Qi Li, Huimin Zhu, Chang Liu, Weiwei Chen, Lingyun Sun

Summary: The activation of the inflammasome plays a critical role in the pathogenesis of systemic lupus erythematosus (SLE), and mesenchymal stem cells (MSC) have been shown to alleviate SLE by suppressing inflammasome activation. This study found that the NLRP3 inflammasome was activated in macrophages from SLE patients and mice, and its activation correlated with disease activity. After MSC transplantation, the severity of SLE was reduced, and NLRP3 inflammasome activation was inhibited. These findings suggest that MSC suppress inflammasome activation and provide a potential therapeutic target for SLE.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Histone deacetylase 3 inhibition alleviates 2,4-dinitrochlorobenzene-in-duced atopic dermatitis via epigenetically upregulating Nrf2/HO-1 signaling pathway

Wei Zhou, Dan Zeng, Shunan Liu, Yunxia Huang, Fenglin Lv, Weikang Zhou

Summary: This study found that inhibiting HDAC3 can protect the skin from atopic dermatitis by activating the Nrf2 transcription to upregulate Nrf2/HO-1 signaling pathway activity.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)